Synthesis and antimicrobial activity of 1-allyloxymethylpyrimidine derivatives
DOI:
https://doi.org/10.12923/j.2084-980X/25.1/a.12Keywords:
1-allyloxymethylpyrimidine derivatives, synthesis, antimicrobial activityAbstract
The ways of obtaining a series of novel pyrimidine derivatives containing allyloxymethyl substituent is presented in position 1. The characterized compounds were tested for antimicrobial activity.
References
1. Al Safarjalani O. et al.: Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio) acyclouridine, a uridine phosphorylase inhibitor, Cancer Chemother. Pharmacol., 58, 692, 2006.
2. Ashour O. et al.: Effect of 5-(phenylselenenyl) acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy, Cancer Chemother. Pharmacol., 46, 235, 2000.
3. Dramiński M. and Frass E.: Synthesis of 8-alkyl derivatives of 9-methyladenine, Polish J. Chem., 61, 901, 1987.
4. El Kouni M. et al.: 5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase, Biochem. Pharmacol., 60, 851, 2000.
5. Kawasaki T. and Kimachi T.: Sparteine-mediated enantioselective [2,3] - Wittig re-arrangement of allyl ortho-substituted benzyl ethers and ortho-substituted benzyl prenyl ethers, Tetrahedron, 55, 6847, 1999.
6. Klein R. et al.: Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase, Biochem. Pharmacol., 62, 1257, 2001.
7. Lashkov A. et al.: Uridine phosphorylase in biomedical, structural, and functional aspects: A review, Crystallogr. Rep., 56, 560, 2011.
8. Melik-Ogandzhanyan R. et al.: Synthesis and biological activity of allylpyrimidines and their derivatives, Khim.-farm. Zh., 17, 190, 1983.
9. Müller C.: Synthesis of 3-substituted 6-aminouracils, Tetrahedron Lett., 32, 6539, 1991.
10. Orr G. et al.: Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils, J. Med. Chem., 38, 3850, 1995.
11. Or, G. et al.: Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl) uracil, J. Med. Chem., 40, 1179, 1997.
12. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. Clinical and Laboratory Standards Institute M100-S16 (M2-A9 and M7-A7), January 2006.
13. Pizzorno G. et al.: Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor, Clin. Cancer Res., 4, 1165, 1998.
14. Prachayasittikul S. et al.: Synthesis of N-substituted 5-iodouracils as antimicrobial and anticancer agents, Molecules, 14, 2768, 2009.
15. Shim, J., Nies R. and Broom A.: Studies on the acylation of some 6-aminouracil derivatives, J. Org. Chem., 37, 578, 1972.
16. Sommadossi J. et al.: Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy, Cancer Chemother. Pharmoacol., 37, 14, 1995.
17. Wróblewski M. et al.: in: Abstracts of the 40th Meeting of the Polish Biochemical Society, Acta Biochim. Pol., Lublin, Poland, 2005, p.146.
Downloads
Published
Issue
Section
License
Copyright (c) 2012 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
